Additionally, IL-6 can activate the mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K), and activator protein-1 (AP-1) pathways [28,29], which contribute to the proliferation and survival of cancer cells. This evidence concerns the gene IL6 and cancer.